Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Comprehensive Technical Guide to ISO 13958 (CAN/CSA-ISO 13958:15) for Haemodialysis Concentrates
Technical Requirements, Implementation Strategies, and Regulatory Compliance for Dialysis Concentrate Manufacturing
The safety and efficacy of haemodialysis treatment are intrinsically linked to the quality of the fluids used during therapy. CAN/CSA-ISO 13958:15, which is the Canadian adoption of ISO 13958, establishes the definitive international requirements for concentrates intended for haemodialysis and related therapies. This standard provides a critical framework for manufacturers, healthcare providers, and regulatory bodies, ensuring consistent purity, performance, and patient safety across the dialysis industry.
Scope and Application of CAN/CSA-ISO 13958:15
CAN/CSA-ISO 13958:15 specifies the minimum quality and safety requirements for concentrates used in haemodialysis, hemofiltration, and hemodiafiltration. It applies to concentrates in various forms:
- Liquid Acid Concentrate — Typically containing electrolytes and acetate or citrate, ready for dilution with water and bicarbonate concentrate.
- Liquid Bicarbonate Concentrate — Highly concentrated sodium bicarbonate solution.
- Dry Powder Concentrates — Intended to be dissolved and mixed on site to create the working concentrate.
The standard covers chemical purity specifications, microbial contamination limits, packaging, labeling, storage requirements, and testing methods. Importantly, it does not cover the quality of the final dialysis fluid, water for dialysis, or the equipment used for mixing. These are governed by the broader ISO 23500 series.
Non-compliance with the chemical purity limits of ISO 13958 can lead to acute patient toxicity, including metal overload syndromes or chloramine-induced hemolysis. Adherence to this standard is not merely a quality measure but a fundamental patient safety requirement and a regulatory obligation under medical device regulations.
Critical Technical Requirements
1. Chemical Purity Specifications
The core of ISO 13958 is its rigorous limits for chemical contaminants. These limits are calculated to ensure that after recommended dilution with water meeting ISO 13959, the final dialysis fluid satisfies the safety thresholds defined in ISO 23500. The standard requires manufacturers to document and control all raw materials and finished products.
| Contaminant | Symbol | Maximum Limit in Concentrate (mg/L)* |
|---|---|---|
| Aluminum | Al | 0.1 |
| Total Chlorine | Cl₂ | 2.0 |
| Chloramines | — | 0.2 |
| Lead | Pb | 0.05 |
| Copper | Cu | 1.0 |
| Zinc | Zn | 1.0 |
| *Limits are expressed per unit volume of concentrate. Final dialysate limits are significantly lower following dilution. Full list includes limits for Ag, As, Ba, Cd, Cr, Hg, Se, Sulfate, and more. | ||
2. Microbiological Quality
ISO 13958 mandates strict limits on bioburden and endotoxins within the concentrate itself. The standard requires that concentrates, when appropriately diluted with water meeting ISO 13959 standards, must result in a final dialysis fluid with less than 100 CFU/mL (colony-forming units) and an endotoxin level below 0.5 EU/mL. Manufacturers must implement validated processes to control microbial growth, particularly in bicarbonate concentrates which are highly susceptible to contamination due to their chemical composition.
3. Packaging, Labeling, and Traceability
The standard specifies detailed requirements for containers to maintain chemical stability, prevent contamination, and ensure safe handling. Labeling must explicitly include:
- Manufacturer details, lot/batch number
- Complete electrolyte composition (in mmol/L for the final solution)
- Exact dilution ratios and mixing instructions
- Storage temperature range and expiration date
- Statement of conformity to ISO 13958
Clear and accurate labeling compliant with ISO 13958 reduces the risk of medication errors in the dialysis clinic. Precise identification of electrolyte concentrations, especially potassium and calcium, is critical for customizing treatment to individual patient needs and avoiding adverse events.
Implementation Highlights for Manufacturers
Successful implementation of CAN/CSA-ISO 13958:15 requires integration with a robust quality management system, typically certified to ISO 13485. Key implementation strategies include:
- Raw Material Testing: Incoming water and chemical components must be rigorously tested for trace metal impurities and microbial bioburden before production begins.
- Process Validation: Mixing, filtration, and filling processes must be validated to ensure homogeneity, chemical stability, and microbial control throughout the concentrate’s shelf life.
- Stability Studies: Long-term stability studies are required to validate the expiry period and storage conditions, particularly for bicarbonate concentrates which can degrade or foster microbial growth over time.
- Supplier Management: The standard demands strict control over the supply chain. Any change in raw material source requires revalidation of the final product against the impurity limits.
When transitioning to a new supplier of raw chemicals, manufacturers must perform a full risk assessment and reconfirm compliance with the heavy metal and anion limits of ISO 13958. Even slight lot variations in raw materials can impact the final concentrate quality and patient safety.
Compliance and Regulatory Integration
In Canada, Health Canada recognizes CAN/CSA-ISO 13958:15 as a recognized standard supporting compliance with the Canadian Medical Devices Regulations (SOR/98-282). Manufacturers must explicitly reference this Canadian adoption for market authorization.
Globally, ISO 13958 serves as the technical backbone for concentrate quality and is referenced by the European Pharmacopoeia (Ph.Eur.), the US Pharmacopeia (USP 39 / 797), and the Japanese Society for Dialysis Therapy (JSDT) guidelines. Alignment with this standard facilitates international market access and harmonizes quality expectations across jurisdictions.
For compliance audits, regulatory bodies typically evaluate:
- Validation records for manufacturing processes
- Batch records showing test results for all required impurities
- Microbiological monitoring data for production environment and water systems
- Stability data supporting the claimed shelf life
Frequently Asked Questions
Q: What is the difference between ISO 13958 and CAN/CSA-ISO 13958:15?
A: CAN/CSA-ISO 13958:15 is the identical adoption of ISO 13958 endorsed by the Standards Council of Canada (SCC). It does not modify the technical requirements of the international standard but introduces a Canadian national preface and is the officially recognized version for demonstrating compliance with Canadian regulatory requirements. Manufacturers targeting the Canadian market must reference this specific national version.
A: CAN/CSA-ISO 13958:15 is the identical adoption of ISO 13958 endorsed by the Standards Council of Canada (SCC). It does not modify the technical requirements of the international standard but introduces a Canadian national preface and is the officially recognized version for demonstrating compliance with Canadian regulatory requirements. Manufacturers targeting the Canadian market must reference this specific national version.
Q: How does ISO 13958 relate to the ISO 23500 series?
A: ISO 13958 acts as a normative reference within the ISO 23500 series. ISO 13958 defines the manufacturing and quality requirements for the concentrate itself, while the ISO 23500 series provides the overall quality management framework for the entire dialysis fluid pathway, including mixing equipment, monitoring protocols, and final fluid testing at the point of care.
A: ISO 13958 acts as a normative reference within the ISO 23500 series. ISO 13958 defines the manufacturing and quality requirements for the concentrate itself, while the ISO 23500 series provides the overall quality management framework for the entire dialysis fluid pathway, including mixing equipment, monitoring protocols, and final fluid testing at the point of care.
Q: Are there specific analytical methods required for testing?
A: Yes, the standard specifies or references specific analytical techniques. For trace metal detection, methods such as Inductively Coupled Plasma Mass Spectrometry (ICP-MS) or Atomic Absorption Spectroscopy (AAS) are standard. For microbial analysis, validated membrane filtration methods for bioburden and the Limulus Amebocyte Lysate (LAL) test for endotoxins are the accepted practices.
A: Yes, the standard specifies or references specific analytical techniques. For trace metal detection, methods such as Inductively Coupled Plasma Mass Spectrometry (ICP-MS) or Atomic Absorption Spectroscopy (AAS) are standard. For microbial analysis, validated membrane filtration methods for bioburden and the Limulus Amebocyte Lysate (LAL) test for endotoxins are the accepted practices.
Q: Does this standard apply to concentrates used in home haemodialysis?
A: Yes, the requirements for the chemical and microbial quality of the concentrates themselves are identical regardless of the care setting. However, the on-site mixing, storage, and handling procedures in a home environment fall under the broader risk management and patient training framework, typically guided by the equipment manufacturer’s instructions and the principles of the ISO 23500 series.
A: Yes, the requirements for the chemical and microbial quality of the concentrates themselves are identical regardless of the care setting. However, the on-site mixing, storage, and handling procedures in a home environment fall under the broader risk management and patient training framework, typically guided by the equipment manufacturer’s instructions and the principles of the ISO 23500 series.
Last updated: 2026. This article is for informational and educational purposes and should be used in conjunction with the official published text of the relevant standard(s).